BNP Paribas Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $266M | Sell |
|
|||||
2025
Q1 | $308M | Buy |
|
|||||
2024
Q4 | $167M | Buy |
|
|||||
2024
Q3 | $64.1M | Buy |
|
|||||
2024
Q2 | $37.9M | Sell |
|
|||||
2024
Q1 | $48.8M | Sell |
|
|||||
2023
Q4 | $110M | Buy |
|
|||||
2023
Q3 | $73.4M | Buy |
|
|||||
2023
Q2 | $73.7M | Sell |
|
|||||
2023
Q1 | $89.8M | Buy |
|
|||||
2022
Q4 | $79.4M | Sell |
|
|||||
2022
Q3 | $101M | Buy |
|
|||||
2022
Q2 | $101M | Sell |
|
|||||
2022
Q1 | $97.3M | Buy |
|
|||||
2021
Q4 | $100M | Sell |
|
|||||
2021
Q3 | $120M | Sell |
|
|||||
2021
Q2 | $139M | Buy |
|
|||||
2021
Q1 | $110M | Buy |
|
|||||
2020
Q4 | $94.8M | Sell |
|
|||||
2020
Q3 | $110M | Buy |
|
|||||
2020
Q2 | $101M | Buy |
|
|||||
2020
Q1 | $66.2M | Buy |
|
|||||
2019
Q4 | $46.8M | Buy |
|
|||||
2019
Q3 | $42M | Sell |
|
|||||
2019
Q2 | $57.8M | Sell |
|
|||||
2019
Q1 | $57.8M | Sell |
|
|||||
2018
Q4 | $56.7M | Sell |
|
|||||
2018
Q3 | $76.3M | Sell |
|
|||||
2018
Q2 | $78.8M | Buy |
|
|||||
2018
Q1 | $65M | Buy |
|
|||||
2017
Q4 | $23.7M | Buy |
|
|||||
2017
Q3 | $13.3M | Sell |
|
|||||
2017
Q2 | $12.1M | Sell |
|
|||||
2017
Q1 | $12.9M | Sell |
|
|||||
2016
Q4 | $51.2M | Buy |
|
|||||
2016
Q3 | $14.8M | Sell |
|
|||||
2016
Q2 | $63.1M | Buy |
|
|||||
2016
Q1 | $43.5M | Sell |
|
|||||
2015
Q4 | $50.2M | Sell |
|
|||||
2015
Q3 | $50.7M | Sell |
|
|||||
2015
Q2 | $62M | Sell |
|
|||||
2015
Q1 | $94.3M | Sell |
|
|||||
2014
Q4 | $126M | Sell |
|
|||||
2014
Q3 | $170M | Sell |
|
|||||
2014
Q2 | $162M | Sell |
|
|||||
2014
Q1 | $163M | Sell |
|
|||||
2013
Q4 | $177M | Buy |
|
|||||
2013
Q3 | $79.7M | Sell |
|
|||||
2013
Q2 | $69.7M | Buy |
|